Soft regulations in pharmaceutical policy making: An overview of current approaches and their Consequences. Wettermark, B., Godman, B., Jacobsson, B., & Haaijer-Ruskamp, F. M. Applied Health Economics and Health Policy, 7(3):137–147, September, 2009.
Paper doi bibtex @article{wettermark_soft_2009-1,
title = {Soft regulations in pharmaceutical policy making: {An} overview of current approaches and their {Consequences}},
volume = {7},
issn = {1175-5652, 1179-1896},
shorttitle = {Soft regulations in pharmaceutical policy making},
url = {http://link.springer.com/10.1007/BF03256147},
doi = {10.1007/BF03256147},
language = {en},
number = {3},
urldate = {2019-05-01},
journal = {Applied Health Economics and Health Policy},
author = {Wettermark, Björn and Godman, Brian and Jacobsson, Bengt and Haaijer-Ruskamp, Flora M.},
month = sep,
year = {2009},
pages = {137--147},
file = {Wettermark et al. - 2009 - Soft regulations in pharmaceutical policy making .pdf:/Users/neil.hawkins/Zotero/storage/GDVW3UZA/Wettermark et al. - 2009 - Soft regulations in pharmaceutical policy making .pdf:application/pdf},
}
Downloads: 0
{"_id":"BPSiDJJATEvjcXYjG","bibbaseid":"wettermark-godman-jacobsson-haaijerruskamp-softregulationsinpharmaceuticalpolicymakinganoverviewofcurrentapproachesandtheirconsequences-2009","author_short":["Wettermark, B.","Godman, B.","Jacobsson, B.","Haaijer-Ruskamp, F. M."],"bibdata":{"bibtype":"article","type":"article","title":"Soft regulations in pharmaceutical policy making: An overview of current approaches and their Consequences","volume":"7","issn":"1175-5652, 1179-1896","shorttitle":"Soft regulations in pharmaceutical policy making","url":"http://link.springer.com/10.1007/BF03256147","doi":"10.1007/BF03256147","language":"en","number":"3","urldate":"2019-05-01","journal":"Applied Health Economics and Health Policy","author":[{"propositions":[],"lastnames":["Wettermark"],"firstnames":["Björn"],"suffixes":[]},{"propositions":[],"lastnames":["Godman"],"firstnames":["Brian"],"suffixes":[]},{"propositions":[],"lastnames":["Jacobsson"],"firstnames":["Bengt"],"suffixes":[]},{"propositions":[],"lastnames":["Haaijer-Ruskamp"],"firstnames":["Flora","M."],"suffixes":[]}],"month":"September","year":"2009","pages":"137–147","file":"Wettermark et al. - 2009 - Soft regulations in pharmaceutical policy making .pdf:/Users/neil.hawkins/Zotero/storage/GDVW3UZA/Wettermark et al. - 2009 - Soft regulations in pharmaceutical policy making .pdf:application/pdf","bibtex":"@article{wettermark_soft_2009-1,\n\ttitle = {Soft regulations in pharmaceutical policy making: {An} overview of current approaches and their {Consequences}},\n\tvolume = {7},\n\tissn = {1175-5652, 1179-1896},\n\tshorttitle = {Soft regulations in pharmaceutical policy making},\n\turl = {http://link.springer.com/10.1007/BF03256147},\n\tdoi = {10.1007/BF03256147},\n\tlanguage = {en},\n\tnumber = {3},\n\turldate = {2019-05-01},\n\tjournal = {Applied Health Economics and Health Policy},\n\tauthor = {Wettermark, Björn and Godman, Brian and Jacobsson, Bengt and Haaijer-Ruskamp, Flora M.},\n\tmonth = sep,\n\tyear = {2009},\n\tpages = {137--147},\n\tfile = {Wettermark et al. - 2009 - Soft regulations in pharmaceutical policy making .pdf:/Users/neil.hawkins/Zotero/storage/GDVW3UZA/Wettermark et al. - 2009 - Soft regulations in pharmaceutical policy making .pdf:application/pdf},\n}\n\n","author_short":["Wettermark, B.","Godman, B.","Jacobsson, B.","Haaijer-Ruskamp, F. M."],"bibbaseid":"wettermark-godman-jacobsson-haaijerruskamp-softregulationsinpharmaceuticalpolicymakinganoverviewofcurrentapproachesandtheirconsequences-2009","role":"author","urls":{"Paper":"http://link.springer.com/10.1007/BF03256147"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/FfNE7kWA6pCvwcJZF/myPubs.bib","dataSources":["ZaHtWavQhcwZqKLNF","iRRNaRs6FkffgErta","v8uQmZsBpiqycmskv"],"keywords":[],"search_terms":["soft","regulations","pharmaceutical","policy","making","overview","current","approaches","consequences","wettermark","godman","jacobsson","haaijer-ruskamp"],"title":"Soft regulations in pharmaceutical policy making: An overview of current approaches and their Consequences","year":2009}